camptothecin has been researched along with dehydroascorbic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, AM; Paquette, B; Sané, AT; Wagner, JR | 1 |
| Aigner, A; Czubayko, F; Frömberg, A; Gutsch, D; Schulze, D; Vollbracht, C; Weiss, G | 1 |
2 other study(ies) available for camptothecin and dehydroascorbic acid
| Article | Year |
|---|---|
Ascorbate modulation of H(2)O(2) and camptothecin-induced cell death in Jurkat cells.
Topics: Ascorbic Acid; Camptothecin; Cell Death; Dehydroascorbic Acid; Enzyme Inhibitors; Humans; Hydrogen Peroxide; Jurkat Cells; Time Factors; Topoisomerase I Inhibitors | 2004 |
Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs.
Topics: Antineoplastic Agents; Apoptosis; Ascorbic Acid; Camptothecin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dehydroascorbic Acid; Docetaxel; Drug Synergism; Epirubicin; Humans; Irinotecan; Male; Organoplatinum Compounds; Oxaliplatin; Prostatic Neoplasms; Taxoids; Vinblastine; Vinorelbine | 2011 |